Results 11 to 20 of about 173,572 (181)

Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. [PDF]

J Med Virol, 2020
Lagunas-Rangel FA.
europepmc   +6 more sources

Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer. [PDF]

Onco Targets Ther, 2021
The inflammatory indexes are attracting increasing attention as a prognostic predictor for colorectal cancer (CRC). However, the prognostic value of the preoperative lymphocyte-to-C-reactive protein ratio (LCR) in patients with non-metastatic CRC remains to be established.A total of 955 patients from 2010 to 2014 at a single center were included ...
Ou W, Zhou C, Zhu X, Lin L, Xu Q.
europepmc   +5 more sources

Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19. [PDF]

J Clin Med Res, 2020
Systemic inflammation elicited by a cytokine storm is considered a hallmark of coronavirus disease 2019 (COVID-19). This study aims to assess the validity and clinical utility of the lymphocyte-to-C-reactive protein (CRP) ratio (LCR), typically used for gastric carcinoma prognostication, versus the neutrophil-to-lymphocyte ratio (NLR) for predicting in-
Ullah W, Basyal B, Tariq S, Almas T, Saeed R, Roomi S, Haq S, Madara J, Boigon M, Haas DC, Fischman DL.   +10 more
europepmc   +5 more sources

The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment. [PDF]

In Vivo, 2022
We investigated the association of the preoperative lymphocyte-to-C-reactive-protein ratio (LCR) with gastric cancer survival and recurrence after curative treatment.This study included 480 patients who underwent curative surgery followed by adjuvant treatment for gastric cancer between 2013 and 2017.
Aoyama T, Nakazano M, Nagasawa S, Hara K, Komori K, Tamagawa H, Maezawa Y, Segami K, Kano K, Ogata T, Yukawa N, Rino Y, Oshima T.   +12 more
europepmc   +4 more sources

Lymphocyte-to-C-reactive protein ratio predicts prognosis in unresectable locally advanced non-small cell lung cancer patients. [PDF]

Ann Med
The lymphocyte-to-C-reactive protein ratio (LCR) is a promising inflammation-based tool for assessing the status of patients with malignant tumours. This study evaluated the ability of LCR to predict the prognosis of patients with unresectable locally advanced non-small cell lung cancer (LA-NSCLC) after chemoradiotherapy.
Xu Y, Li J, Ji X, Chen Q, Liu Z, Ji S.
europepmc   +4 more sources

The role of the lymphocyte-to-C-reactive protein ratio in obstructive sleep apnea

Neurological Sciences and Neurophysiology, 2020
Context: This was an investigation of inflammation markers on the prediction and prognosis of patients with sleep apnea. Aims: Clinical detection of inflammatory markers is useful to assess systemic inflammation in patients with obstructive sleep apnea ...
Sabri Koseoglu, Yasemin Unal, Ercan Saruhan, Vedat Semai Bek, Gulnihal Kutlu   +4 more
doaj   +3 more sources

Association of lymphocyte-to-C-reactive protein ratio with all-cause and cause-specific mortality among US cancer survivors. [PDF]

Eur J Med Res
Lymphocyte-to-C-reactive protein ratio (LCR) has been linked to survival in malignancies. However, most studies are from Asia. The knowledge about the link between LCR levels and risks of all-cause mortality and cause-specific mortality among cancer participants in the US is lacking.Using multivariable Cox proportional hazards regression, we ...
Nong J, Wang R, Zhang Y.
europepmc   +4 more sources

Lymphocyte-to-C-reactive protein ratio and score in patients with heart failure: Nutritional status, physical function, and prognosis. [PDF]

ESC Heart Fail
AbstractAimsIn heart failure (HF), inflammation is linked to malnutrition and impaired physical function. In this study, we aimed to assess how novel nutritional–inflammatory markers and lymphocyte‐to‐C‐reactive protein ratio (LCR) and score (LCS) are associated with the nutritional status, physical function, and prognosis of patients with HF.Methods ...
Maeda D, Matsue Y, Kagiyama N, Fujimoto Y, Sunayama T, Dotare T, Nakade T, Jujo K, Saito K, Kamiya K, Saito H, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Hiki M, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Wakaume K, Oka K, Momomura SI, Minamino T.   +27 more
europepmc   +4 more sources

C-Reactive Protein-to-Albumin Ratio (CAR) and C-Reactive Protein-to-Lymphocyte Ratio (CLR) are Valuable Inflammatory Biomarker Combination for the Accurate Prediction of Periprosthetic Joint Infection

Infection and Drug Resistance, 2023
Weipeng Shi,1,2 Yaping Jiang,3 Hua Tian,4 Yingzhen Wang,1 Yingze Zhang,5 Tengbo Yu,1 Tao Li1 1Department of Orthopaedic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China; 2Medical Department of Qingdao University,
Shi W, Jiang Y, Tian H, Wang Y, Zhang Y, Yu T, Li T   +6 more
doaj   +2 more sources

Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study [PDF]

Journal of Inflammation Research, 2022
Li Wang,1,* Yu-Ling Zhang,2,* Chang Jiang,1,* Fang-Fang Duan,1 Zhong-Yu Yuan,1 Jia-Jia Huang,1 Xi-Wen Bi1 1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine ...
Wang L, Zhang YL, Jiang C, Duan FF, Yuan ZY, Huang JJ, Bi XW   +6 more
doaj   +2 more sources